搜索结果: 1-15 共查到“医学 Parkinson”相关记录21条 . 查询时间(0.051 秒)
第14届国际阿尔兹海默病和帕金森病大会会议（The 14th International Conference on Alzheimer’s & Parkinson’s Diseases, AD/PDTM 2019）
第14届 阿尔兹海默病 帕金森病 大会会议
2018/5/23
第14届国际阿尔兹海默病和帕金森病大会会议 (The 14th International Conference on Alzheimer’s & Parkinson’s Diseases, AD/PDTM 2019) 将于2019年3月26日-- 31日在历史悠久、风光秀丽的欧洲名城葡萄牙首都里斯本举行。本次大会主题：神经退行性疾病机理、临床策略和未来诊疗方法。参会者将包括众多临床医学工作者、基...
Tactic For Controlling Motor Symptoms Of Advanced Parkinson's（图）
Tactic Controlling Motor Symptoms Advanced Parkinson's
2018/2/1
Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility. These complications include abnormal involuntary movements...
Robotic Device Improves Balance And Gait In Parkinson’s Disease Patients（图）
Robotic Device Balance Gait Parkinson’s Disease Patients
2018/1/10
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative d...
Researchers discover neuronal targets that restore movement in Parkinson's disease model
Researchers neuronal targets restore movement Parkinson's disease model
2017/7/20
Researchers working in the lab of Carnegie Mellon University neuroscientist Aryn Gittis have identified two groups of neurons that can be turned on and off to alleviate the movement-related symptoms o...
2017年帕金森病高登研究研讨会（The Gordon Research Seminar on Parkinson's Disease）
Parkinson's Disease therapeutic interventions
2017/3/7
Applications for this meeting must be submitted by May 27, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be st...
2017帕金森氏病戈登学术会议（The 2017 Gordon Research Conference on Parkinson’s Disease）
Parkinson’s Disease therapeutics
2017/1/18
The Gordon Research Conference on Parkinson's disease is a unique meeting within the field that brings together scientists across myriad disciplines and from varied backgrounds and positions around th...
Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease
Depression Parkinson Disease Prevalence Anhedonia
2015/11/9
Background: The factors affecting the correlation between Parkinson disease (PD) and depression have remained unclear.
第二届台湾帕金森及运动障碍疾病研讨会（2nd Taiwan International Congress of Parkinson’s Disease and Movement Disorders)
第二届 台湾帕金森及运动障碍疾病 研讨会
2015/1/12
The Scientific Program Committee of 2015 TIC-PDMD invites all interested individuals to submit abstracts. The abstract submission starts on September 1, 2014.
Please note that all the accepted submis...
汕头大学医学院药理学课件 Drugs of Anti-Parkinson’s disease
汕头大学医学院 药理学 课件 Drugs of Anti-Parkinson’s disease
2014/6/25
汕头大学医学院药理学课件 Drugs of Anti-Parkinson’s disease。
A smartphone app has been developed to help monitor and improve treatments for people with Parkinson’s disease.
汕头大学医学院药理学精品课程 Drugs of Anti-Parkinson’s disease
汕头大学 医学院 药理学 精品课程 Drugs of Anti-Parkinson’s disease
2013/11/7
汕头大学医学院药理学精品课程 Drugs of Anti-Parkinson’s disease。
Parkinson’s patients advised to seek Deep Brain Stimulation treatment in early stages（图）
Parkinson’s patients Deep Brain Stimulation treatment
2014/7/11
People with Parkinson’s disease who receive Deep Brain Stimulation (DBS) therapy in the early stages of the condition will benefit from a significant increase in quality of life, a revolutionary study...
Efficacy of rehabilitation program in addition to pharmacological treatment during 8 months in Parkinson patients
Parkinson Rehabilitation UPDRS
2013/1/29
To compare 8-month effects of medical treatment plus rehabilitation on UPDRS scores of parkinsonian patients with that of medical treat- ment without rehabilitation. Design: Longtudinal randomized stu...
Prenatal and Postnatal Exposures to 1-Methyl-4-phenyl-1,2,3,6-tetra Hydropyridine (MPTP) Impaired Mouse Midbrain Dopamine System and May Produce a Predisposing and Inducing Model for Parkinson’s Disease
Parkinson’s Disease Midbrain -Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)
2013/1/29
Dopamine cell bodies in the substantia nigra of the midbrain and with their terminals projecting to the neostriatum form the nigrostriatum and these dopamine neurons degenerate in Parkinson’s disease ...
Dorsolateral Prefrontal Cortex: A Possible Target for Modulating Dyskinesias in Parkinson's Disease by Repetitive Transcranial Magnetic Stimulation
Dorsolateral Prefrontal Cortex Modulating Dyskinesias
2009/9/4
We studied whether five sessions of 10 Hz repetitive transcranial magnetic stimulation (rTMS treatment) applied over the dorsolateral prefrontal cortex (DLPFC) or the primary motor cortex (MC) i...